20 assets in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type

Therapeutic assets addressing Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Adriamycin Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Northwestern University	P2/3	BB (64)
Prednisone Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Northwestern University	P2/3	BB (64)
Vincristine Sulfate Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Northwestern University	P2/3	BB (64)
Cyclophosphamide Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Mayo Clinic	P2/3	B (63)
Rituximab Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Mayo Clinic	P2/3	B (63)
Azacitidine Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	National Cancer Institute (NCI)	P2/3	B (57)
Lenalidomide Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	David Bond, MD	P2	B (57)
Recombinant Human Hyaluronidase Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	National Cancer Institute (NCI)	P2/3	B (57)
Carboplatin Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	David Bond, MD	P2	CCC (53)
Etoposide Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	David Bond, MD	P2	CCC (53)
Golcadomide Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Mayo Clinic	P2	CCC (53)
Isocyclophosphamide Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	David Bond, MD	P2	CCC (53)
Nivolumab Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	National Cancer Institute (NCI)	P2	CCC (53)
Ontorpacept Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Mayo Clinic	P2	CCC (53)
Pembrolizumab Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Mayo Clinic	P2	CCC (53)
Tafasitamab Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	David Bond, MD	P2	CCC (53)
Zanubrutinib Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Northwestern University	P2	CCC (53)
1-118-Signal regulatory protein ? (human) fusion protein with immunoglobulin G4 [128-proline] (human ?4-chain C region C-terminal fragment), dimer Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Mayo Clinic	P2	CC (45)
Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	National Cancer Institute (NCI)	P2	CC (44)
Sgr-1505 Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type	Schrödinger, Inc.	P1	NR ()